Researchers at Vanderbilt University have identified a potential new drug target in subtypes of lung cancer that are difficult to treat.

The extracellular matrix that surrounds cells plays a role in the development of insulin resistance.

A long-term Vanderbilt University Medical Center study of deep brain stimulation (DBS) in early-stage Parkinson’s disease has received approval from the Food and Drug Administration (FDA) to continue in a pivotal, phase III, large-scale safety and efficacy trial.

One of the most formidable weapons in a cancer’s arsenal is the ability to spread to other organs.

Walk into ophthalmologist Anita Agarwal’s office at the Vanderbilt Eye Institute and there is something remarkably different about the décor.

Vanderbilt University Medical Center has been selected as one of three sites to share a three-year, $1.3 million grant from the National Institutes of Health (NIH) to explore the potential therapeutic properties of manganese, a chemical element and biologically essential trace mineral, in treating Restless Legs Syndrome (RLS).

More than 15 million women in the United States are impacted by stress urinary incontinence (SUI) at a cost of nearly $20 billion a year to treat.